Next-generation sequencing of circulating tumor DNA to predict recurrence in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy

Next-generation sequencing of circulating tumor DNA to predict recurrence in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy

The following license files are associated with this item:

This item appears in the following Collection(s)

Attribution 3.0 United States Except where otherwise noted, this item's license is described as Attribution 3.0 United States

Search Repository


My Account

Statistics